DCGI approves Itolizumab for restricted emergency use in COVID-19 treatment
The approval was given after its clinical trials on COVID-19 patients in India was found satisfactory by an expert committee,…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.